These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22998551)

  • 1. Novel FabH inhibitors: a patent and article literature review (2000--2012).
    Luo Y; Yang YS; Fu J; Zhu HL
    Expert Opin Ther Pat; 2012 Nov; 22(11):1325-36. PubMed ID: 22998551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
    Gadakh B; Van Aerschot A
    Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping.
    McKinney DC; Eyermann CJ; Gu RF; Hu J; Kazmirski SL; Lahiri SD; McKenzie AR; Shapiro AB; Breault G
    ACS Infect Dis; 2016 Jul; 2(7):456-64. PubMed ID: 27626097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial agents: patent highlights January to June 2003.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Aug; 4(8):926-36. PubMed ID: 14508876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
    ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial acetohydroxyacid synthase and its inhibitors--a summary of their structure, biological activity and current status.
    Gedi V; Yoon MY
    FEBS J; 2012 Mar; 279(6):946-63. PubMed ID: 22284339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
    Ramamoorthy D; Turos E; Guida WC
    J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J; Lv PC; Zhu HL
    Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
    Wang YT; Shi TQ; Fu J; Zhu HL
    Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
    Li HQ; Luo Y; Lv PC; Shi L; Liu CH; Zhu HL
    Bioorg Med Chem Lett; 2010 Mar; 20(6):2025-8. PubMed ID: 20153183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.
    Wang J; Hudson R; Sintim HO
    Future Med Chem; 2012 Jun; 4(9):1113-51. PubMed ID: 22709254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New substituted benzimidazole derivatives: a patent review (2010 - 2012).
    Fei F; Zhou Z
    Expert Opin Ther Pat; 2013 Sep; 23(9):1157-79. PubMed ID: 23675911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.